Shih-Pin Chen
Clinical Neuroscience
Name Shih-Pin Chen
Email spchen2@vghtpe.gov.tw
POSITION TITLE/AFFILIATIONS 台北榮民總醫院神經內科主治醫師
台北榮民總醫院醫學研究部轉譯研究科主治醫師
台北榮民總醫院醫學科技大樓管理中心主任
國立陽明大學臨床醫學研究所副教授
國立陽明大學神經科學研究所副教授
國立陽明大學醫學系神經學科副教授
中研院跨領域神經科學-國際研究生博士班學程 (TIGP-INS)副教授
EDUCATION/TRAINING 國立陽明大學醫學士
國立陽明大學臨床醫學研究所博士
哈佛醫學院麻州總醫院神經血管研究室博士後研究員
Research Headache, Neurodegenerative diseases, Neuroimmunological disorders
Year Paper Title
2021 11, 2, pp166-
2021
2020 21, 1, pp133-
2018 Chen SP¶, Fuh JL¶, Chung MY¶, Lin YC, Liao YC, Wang YF, Hsu CL, Yang YC, Lin MW, Chiou JJ, Wang PJ, Chen PK, Fan PC, Wu JY, Chen YT, Kao LS*, Fann CS*, Wang SJ*. Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan. Cephalalgia 2018; 38: 466-75
2018 Chen SP,* Chou KH,¶ Fuh JL,¶ Huang YH, Huang CC, Lirng JF, Wang YF, Lin CP, Wang SJ.* Dynamic Changes in White Matter Hyperintensities in Reversible Cerebral Vasoconstriction Syndrome. JAMA Neurology 2018 in press (*Equal contribution; ¶Equal contribution)
2018 Chou TM, Chen SP*. Animal Models of Chronic Migraine. Current Pain and Headache Reports. 2018 in press
2017 Chen SP, Qin T, Seidel JL, Zheng Y, Eikermann M, Ferrari MD, van den Maagdenberg AM., Moskowitz MA, Ayata C, Eikermann-Haerter K. Inhibition of the P2X7-pannexin 1 complex suppresses spreading depolarization and neuroinflammation. Brain 2017; 140:1643-1656
2017 Chen SP, Ayata C.* Novel Therapeutic Targets against Spreading Depression. Headache 2017;57:1340-1358
2016 Chen SP,* Ay I, Lopes de Morais A, Qin T, Zheng Y, Sadeghian H, Oka F, Simon B, Eikermann-Haerter K, Ayata C. Vagus nerve stimulation inhibits cortical spreading depression. Pain 2016; 157: 797-805
2016 Chen SP, Ayata C.* Spreading Depression in Primary and Secondary Headache Disorders. Current Pain and Headache Reports. 2016; 20(7):44
2016 Chen SP, Tolner EA,* Eikermann-Haerter K.* Animal models of monogenic migraine. Cephalalgia 2016; 36: 704-21
2015 Chen SP, Fuh JL, Lirng JF, Wang YF, Wang SJ.* Recurrence of Reversible Cerebral Vasoconstriction Syndrome: a Long-Term Follow-up Study. Neurology 2015; 84: 1-7
2013 Chen SP, Chung YT, Liu TY, Wang YF, Fuh JL,* Wang SJ.* Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radical Biology & Medicine. 2013;61C:243-248
2012 Chen SP, Fuh JL, Lirng JF, Wang SJ.*Hyperintense vessels on FLAIR imaging in reversible cerebral vasoconstriction syndromes. Cephalalgia 2012; 32:271-8
2011 Chen SP, Fuh JL, Wang SJ.* Reversible cerebral vasoconstriction syndromes: Current and future perspectives. Expert Rev Neurother 2011; 11:1265-76
2010 Chen SP, Fuh JL, Wang SJ,* Chang FC, Lirng JF, Fang YC, Shia BC, Wu JC. Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Annals of Neurology 2010; 67: 648-56
2010 Chen SP, Fuh JL, Wang SJ.* Reversible cerebral vasoconstriction syndromes- an under-recognised clinical emergency. Ther Adv Neurol Disord 2010; 3: 161-71.
2008 Chen SP, Fuh JL, Chang FC, Lirng JF, Shia BC, Wang SJ.* A transcranial color doppler study for reversible cerebral vasoconstriction syndromes. Annals of Neurology 2008; 63: 751-7
2006 Chen SP, Fuh JL, Lirng JF, Chang FC, Wang SJ.* Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology. 2006;67:2164-9